Dr. David Shashar (MD, Ob/Gyn, MBA, BME)
CEO and Founder
David Shashar received his medical degree from the Hebrew University in Jerusalem and is board certified in obstetrics and gynecology. He holds an executive MBA from the Kellogg-Recanati Business School and a MSc in biomedical engineering from the Technion-Israel Institute of Technology.
Prior to leading PregnanTech, David was the medical director of multidisciplinary collaboration platforms at Sheba Medical Center, assigned to proactively align physicians and engineers from the Israeli medical industry and academia to develop cost-effective, innovative medical technology solutions to meet pressing clinical problems. He has extensive experience in inventing, innovating and developing new medical technologies.
Ms. Limor Sandach
Chairwoman of the board
Ms. Sandach holds BSc in Chemical engineering and ME in industrial Design from the Technion Israel Institute of Technology, Haifa, Israel. Limor is a senior manager with over 20 years of experience investing in healthcare innovation and managing start-ups in medical devices. Limor served as CEO of AV Medical Technologies. During her tenure, AV completed product development, obtained CE and FDA approvals, and began generating sales in the United States. Following a successful partnership, AV was acquired by Medtronic in late 2019.
In Parallel, Limor was a partner in Access Medical Ventures (AMV), invested and served as a director in medical device start-ups. Prior to that, Limor served at management positions in healthcare VCs – 7Healthventures, Evergreen and XT – leading due diligence and portfolio development.
Ms. Nufar Bar-Or
Nufar holds a BSc in Biology and Cognitive Science from the Hebrew University in Jerusalem and possesses over eight years of experience in the field of medical device as a Clinical Research Associate and Clinical Trials Manager. During her tenure in a leading regulatory affairs consulting company, Nufar has monitored and managed multiple clinical trials conducted worldwide, for a variety of medical device companies.
Mr. Steve Rhodes
Mr. Rhodes is the chairman and founder of The Trendlines Group. Steve holds a BA from Harvard University and holds an MBA from the University of Chicago. He has extensive investment experience and serves as a director in many of Trendlines' portfolio companies. Mr. Rhodes has years of management experience, including in-depth understanding of all the financial and organizational requirements for commercial exploitation of start-up companies. Steve has been active in the medical device industry for more than 30 years, first as a senior executive in a medical device company and subsequently as an investor, director, and mentor.
Prof. Eyal Schiff
Formerly the Chairman of the Obstetrics and Gynecology Division at Sheba Medical Center, Tel-Aviv University Israel. Professor Schiff headed Sheba's high-risk obstetrics and prenatal services departments. He has published over 100 academic papers in his field. Prof. Schiff has extensive experience in managing medical organizations with large teams, experience as CEO and COO of technology startup companies, healthy relationships with the VC industry and experience as a director and investor in several other biotech innovative start-up companies in the computational and pharma fields.
Ms. Buffy Alegria
Ms. Alegria is a Femtech financial entrepreneur, angel investor, advisor, mentor, and venture capitalist. She is a Managing Partner of SteelSky Ventures LLC, an investing member in the SeaChange Fund, Portfolia's Femtech Fund, Sage Growth Capital and Pipeline Angels. Her professional background includes numerous roles in corporate banking, risk management, project management and healthcare. Buffy serves on the board of the Virginia Mason Memorial Hospital and the Washington State Hospital Association. She earned an MST from Oregon Graduate Institute of Science & Technology and BS in Psychology & Biology from Pacific University.